{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:31:50Z","timestamp":1793309510002,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002826","name":"CSIR - Indian Institute of Chemical Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["OLP-015"],"award-info":[{"award-number":["OLP-015"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bbrc.2026.154568","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:31:11Z","timestamp":1789054271000},"page":"154568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Mitochondria-targeted esculetin mitigates age-associated cardiac remodeling through coordinated activation of AMPK-SIRT1 and inhibition of p38 MAPK signaling"],"prefix":"10.1016","volume":"836","author":[{"given":"Hridya","family":"Chempon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sriravali","family":"Pulipaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Altab","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogesh","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai Krishna","family":"Ganji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajamannar","family":"Thennati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0525-7553","authenticated-orcid":false,"given":"Srigiridhar","family":"Kotamraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.154568_bib1","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1161\/01.CIR.0000120390.68287.BB","article-title":"Hypertrophy of the heart: a new therapeutic target?","volume":"109","author":"Frey","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2026.154568_bib2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","article-title":"Mechanisms of physiological and pathological cardiac hypertrophy","volume":"15","author":"Nakamura","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.bbrc.2026.154568_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914845","article-title":"Myocardial fibrosis in hypertrophic cardiomyopathy: a perspective from fibroblasts","volume":"24","author":"Schlittler","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.154568_bib4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.yjmcc.2016.06.001","article-title":"Physiological and pathological cardiac hypertrophy","volume":"97","author":"Shimizu","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbrc.2026.154568_bib5","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/cvr\/cvaa324","article-title":"Cardiac fibrosis","volume":"117","author":"Frangogiannis","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbrc.2026.154568_bib6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.arr.2014.12.001","article-title":"Aging and dyslipidemia: a review of potential mechanisms","volume":"19","author":"Liu","year":"2015","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.bbrc.2026.154568_bib7","article-title":"Cardiac aging: from hallmarks to therapeutic opportunities","author":"Hastings","year":"2024","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbrc.2026.154568_bib8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1423-0127-19-22","article-title":"Cardiac and vascular phenotypes in the apolipoprotein E-deficient mouse","volume":"19","author":"Vasquez","year":"2012","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.bbrc.2026.154568_bib9","article-title":"Senescent cardiac fibroblast is critical for cardiac fibrosis after myocardial infarction","volume":"8","author":"Zhu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2026.154568_bib10","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.7150\/thno.51739","article-title":"Deficiency of telomere-associated repressor activator protein 1 precipitates cardiac aging in mice via p53\/PPAR\u03b1 signaling","volume":"11","author":"Cai","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.bbrc.2026.154568_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077034","article-title":"Bradykinin inhibits oxidative stress-induced cardiomyocytes senescence via regulating redox state","volume":"8","author":"Dong","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2026.154568_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11020336","article-title":"The role of oxidative stress in the aging heart","volume":"11","author":"Pagan","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.bbrc.2026.154568_bib13","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019948","article-title":"Effects of aging on cardiac oxidative stress and transcriptional changes in pathways of reactive oxygen species generation and clearance","volume":"10","author":"Rizvi","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.bbrc.2026.154568_bib14","first-page":"158","article-title":"Aging and cardiac fibrosis","volume":"2","author":"Biernacka","year":"2011","journal-title":"Aging Dis"},{"key":"10.1016\/j.bbrc.2026.154568_bib15","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCRESAHA.110.232306","article-title":"Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and galphaq overexpression-induced heart failure","volume":"108","author":"Dai","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2026.154568_bib16","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1161\/CIRCULATIONAHA.108.822403","article-title":"Overexpression of catalase targeted to mitochondria attenuates murine cardiac aging","volume":"119","author":"Dai","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2026.154568_bib17","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ejphar.2015.09.035","article-title":"Insulin sensitizing and cardioprotective effects of esculetin and telmisartan combination by attenuating ang II mediated vascular reactivity and cardiac fibrosis","volume":"765","author":"Kadakol","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.154568_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113001","article-title":"Improvement effects of esculetin on the formation and development of atherosclerosis","volume":"150","author":"Wang","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbrc.2026.154568_bib19","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1007\/s11357-023-01015-w","article-title":"Therapeutic efficacies of mitochondria-targeted esculetin and metformin in the improvement of age-associated atherosclerosis via regulating AMPK activation","volume":"46","author":"Pulipaka","year":"2024","journal-title":"GeroScience"},{"key":"10.1016\/j.bbrc.2026.154568_bib20","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.atherosclerosis.2022.07.012","article-title":"Mitochondria-targeted esculetin mitigates atherosclerosis in the setting of aging via the modulation of SIRT1-mediated vascular cell senescence and mitochondrial function in Apoe(-\/-) mice","volume":"356","author":"Karnewar","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbrc.2026.154568_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/srep24108","article-title":"Mitochondria-targeted esculetin alleviates mitochondrial dysfunction by AMPK-mediated nitric oxide and SIRT3 regulation in endothelial cells: potential implications in atherosclerosis","volume":"6","author":"Karnewar","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2026.154568_bib22","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.3390\/cells15151408","article-title":"Metformin inhibits cardiac fibroblast differentiation by promoting fatty acid \u03b2-Oxidation: implications for age-associated cardiac fibrosis","volume":"15","author":"Chempon","year":"2026","journal-title":"Cells"},{"key":"10.1016\/j.bbrc.2026.154568_bib23","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.bbadis.2018.01.018","article-title":"Metformin regulates mitochondrial biogenesis and senescence through AMPK mediated H3K79 methylation: relevance in age-associated vascular dysfunction","volume":"1864","author":"Karnewar","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.bbrc.2026.154568_bib24","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ijcard.2011.09.012","article-title":"Cardiac fibrosis and vascular remodeling are attenuated by metformin in obese rats","volume":"165","author":"Burl\u00e1","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.bbrc.2026.154568_bib25","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015154","article-title":"Metformin improves cardiac metabolism and function, and prevents left ventricular hypertrophy in spontaneously hypertensive rats","volume":"9","author":"Li","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.bbrc.2026.154568_bib26","doi-asserted-by":"crossref","first-page":"12283","DOI":"10.1073\/pnas.211086598","article-title":"The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy","volume":"98","author":"Liao","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2026.154568_bib27","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cardfail.2004.04.004","article-title":"Inhibition of p38 mitogen-activated protein kinase protects the heart against cardiac remodeling in mice with heart failure resulting from myocardial infarction","volume":"11","author":"Liu","year":"2005","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.bbrc.2026.154568_bib28","doi-asserted-by":"crossref","first-page":"12329","DOI":"10.1039\/D1CC03497A","article-title":"A functional and self-assembling octyl-phosphonium-tagged esculetin as an effective siRNA delivery agent","volume":"57","author":"Shaikh","year":"2021","journal-title":"Chem. Commun."},{"key":"10.1016\/j.bbrc.2026.154568_bib29","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00109-024-02449-1","article-title":"Mitochondria targeted esculetin administration improves insulin resistance and hyperglycemia-induced atherosclerosis in db\/db mice","volume":"102","author":"Singuru","year":"2024","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.bbrc.2026.154568_bib30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.18632\/aging.100527","article-title":"Specific lipofuscin staining as a novel biomarker to detect replicative and stress-induced senescence. A method applicable in cryo-preserved and archival tissues","volume":"5","author":"Georgakopoulou","year":"2013","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bbrc.2026.154568_bib31","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/0003-2697(76)90326-2","article-title":"A fluorometric method for determination of oxidized and reduced glutathione in tissues","volume":"74","author":"Hissin","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbrc.2026.154568_bib32","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/mc.22996","article-title":"Doxorubicin induces prostate cancer drug resistance by upregulation of ABCG4 through GSH depletion and CREB activation: relevance of statins in chemosensitization","volume":"58","author":"Mallappa","year":"2019","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.bbrc.2026.154568_bib33","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000241","article-title":"Hypercholesterolemia induces oxidant stress that accelerates the ageing of hematopoietic stem cells","volume":"3","author":"Tie","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.bbrc.2026.154568_bib34","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1161\/CIRCULATIONAHA.116.024599","article-title":"Cardiac fibroblast-specific activating transcription factor 3 protects against heart failure by suppressing MAP2K3-p38 signaling","volume":"135","author":"Li","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2026.154568_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21197412","article-title":"p38 MAPK pathway in the heart: new insights in health and disease","volume":"21","author":"Romero-Becerra","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.154568_bib36","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1161\/CIRCRESAHA.111.246876","article-title":"The intersection between aging and cardiovascular disease","volume":"110","author":"North","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2026.154568_bib37","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.freeradbiomed.2018.02.031","article-title":"Metformin treatment prevents SREBP2-mediated cholesterol uptake and improves lipid homeostasis during oxidative stress-induced atherosclerosis","volume":"118","author":"Gopoju","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbrc.2026.154568_bib38","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.2337\/db14-1225","article-title":"Metformin inhibits monocyte-to-macrophage differentiation via AMPK-mediated inhibition of STAT3 activation: potential role in atherosclerosis","volume":"64","author":"Vasamsetti","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.bbrc.2026.154568_bib39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.14336\/AD.2021.0927","article-title":"Cellular senescence in cardiovascular diseases: a systematic review","volume":"13","author":"Hu","year":"2022","journal-title":"Aging Dis"},{"key":"10.1016\/j.bbrc.2026.154568_bib40","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jacbts.2023.12.003","article-title":"Cellular senescence as a targetable risk factor for cardiovascular diseases: therapeutic implications: JACC family series","volume":"9","author":"Kumar","year":"2024","journal-title":"JACC, Basic Transl. Sci."},{"key":"10.1016\/j.bbrc.2026.154568_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.44","article-title":"Reactive oxygen species and p21Waf1\/Cip1 are both essential for p53-mediated senescence of head and neck cancer cells","volume":"6","author":"Fitzgerald","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2026.154568_bib42","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0891-5849(02)00959-0","article-title":"Lipofuscin: mechanisms of age-related accumulation and influence on cell function","volume":"33","author":"Brunk","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbrc.2026.154568_bib43","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/cvr\/cvr015","article-title":"Mitochondrial adaptations to physiological vs. pathological cardiac hypertrophy","volume":"90","author":"Abel","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbrc.2026.154568_bib44","doi-asserted-by":"crossref","first-page":"5362","DOI":"10.18632\/aging.102956","article-title":"Delphinidin attenuates pathological cardiac hypertrophy via the AMPK\/NOX\/MAPK signaling pathway","volume":"12","author":"Chen","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bbrc.2026.154568_bib45","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/cvr\/cvq376","article-title":"Sirt1 acts in association with PPAR\u03b1 to protect the heart from hypertrophy, metabolic dysregulation, and inflammation","volume":"90","author":"Planavila","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbrc.2026.154568_bib46","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.tem.2017.05.004","article-title":"AMPK as a therapeutic target for treating metabolic diseases","volume":"28","author":"Day","year":"2017","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.bbrc.2026.154568_bib47","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3109\/10409238.2013.789479","article-title":"NAD+ metabolism: a therapeutic target for age-related metabolic disease","volume":"48","author":"Mouchiroud","year":"2013","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.bbrc.2026.154568_bib48","article-title":"The anti-aging mechanism of metformin: from molecular insights to clinical applications","volume":"30","author":"Zhang","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.bbrc.2026.154568_bib49","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1165\/rcmb.2016-0374OC","article-title":"p38 MAPK inhibition improves heart function in pressure-loaded right ventricular hypertrophy","volume":"57","author":"Kojonazarov","year":"2017","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.bbrc.2026.154568_bib50","first-page":"5402","article-title":"AMPK\/SIRT1\/p38 MAPK signaling pathway regulates alcohol-induced neurodegeneration by resveratrol","volume":"17","author":"Gu","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbrc.2026.154568_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.103878","article-title":"Recent discoveries of the role of histone modifications and related inhibitors in pathological cardiac hypertrophy","volume":"29","author":"Wu","year":"2024","journal-title":"Drug Discov. Today"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2601332X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2601332X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:54:07Z","timestamp":1793307247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X2601332X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":51,"alternative-id":["S0006291X2601332X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154568","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitochondria-targeted esculetin mitigates age-associated cardiac remodeling through coordinated activation of AMPK-SIRT1 and inhibition of p38 MAPK signaling","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154568","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"154568"}}